RxDoctor Payments DataLook up a doctor →

Paul Benson, DO

Family Medicine · Berkley, MINPI 1174554364

Payments from drug & device makers

$4,154,033in general payments, 2019–2025

Across 2,382 payments — averaging $1743.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$2.1M
  • Viiv Healthcare Company$1.7M
  • Merck$149K
  • GSK$82K
  • Janssen Research & Development, LLC$41K
  • Janssen Products, LP$35K
  • plus $49K from 45 others
$5,459in research payments, 2019–2025

Across 34 payments — averaging $160.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$2K
  • Gilead$2K
  • Viiv Healthcare Company$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,154,033 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$64,389
Medicare patients
186
Services billed
4,217

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Berkley

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →